Company profile
Multicorp International, Inc.
OTC: MCIC · Healthcare · Medical - Distribution
#1163 of 1,418 Healthcare companies by revenue
EA Score
——FH 64DQ —GM —SS 60
v0.1 · 35/100 weight · pillars only
↑ balance-sheet leverage, listing tenure · ↓ Piotroski F, market scale
Methodology →Revenue TTM
$0
Rev growth YoY (TTM)
needs 8 qtrs
Net income (FY)
-$25.7k
Employees
—
as of 2026-09-26
Market cap
$912.5k
as of 2026-09-26
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$0$02025
Net income-$25.7k-$25.7k2025
Operating income-$6.7k-$6.7k2025
Total assets$5.2M$5.2M2025
Liabilities$422.6k$422.6k2025
Equity$4.8M$4.8M2025
Revenue trend
FY2014 – FY2025 · USD
FY14
FY19
FY20
FY21
FY22
FY23
FY24
FY25
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is Multicorp International, Inc.’s revenue?
Multicorp International, Inc. booked $0 in FY2025 revenue — among the slowest-growing Healthcare companies we track, at a -Infinity% net margin.
Peers · Healthcare
Lifeline Biotechnologies, Inc.——Odyssey Health, Inc.21DAvalon GloboCare Corp.35DHepion Pharmaceuticals, Inc.24DGenix Pharmaceuticals Corporation——Apptly Health Technologies Corp.——Neighbors
Los Angeles →Key facts
CEODavid Gustafson
SectorHealthcare
IndustryMedical - Distribution
HeadquartersAgoura Hills, CA
ExchangeOTC: MCIC
Employees—
IPO date1997-09-17
Latest filings
No filings loaded — no CIK (non-SEC filer).
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.